Importance of Clinical Worsening of Heart Failure Treated in the Outpatient Setting
Author(s) -
Naoki Okumura,
Pardeep S. Jhund,
Jianjian Gong,
Martin Lefkowitz,
Adel R. Rizkala,
Jean L. Rouleau,
Victor Shi,
Karl Swedberg,
Michael R. Zile,
Scott D. Solomon,
Milton Packer,
John J.V. McMurray
Publication year - 2016
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.115.020729
Subject(s) - medicine , hazard ratio , heart failure , confidence interval , emergency department , enalapril , valsartan , ace inhibitor , cardiology , angiotensin converting enzyme , blood pressure , psychiatry
Many episodes of worsening of heart failure (HF) are treated by increasing oral therapy or temporary intravenous treatment in the community or emergency department (ED), without hospital admission. We studied the frequency and prognostic importance of these episodes of worsening in the Prospective Comparison of ARNI (angiotensin-receptor-neprilysin inhibitor) with ACEI (angiotensin-converting enzyme inhibitor) to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial (PARADIGM-HF).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom